{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:42:35Z","timestamp":1765546955608,"version":"3.40.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS025984"],"award-info":[{"award-number":["R01HS025984"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05201-5","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T17:03:33Z","timestamp":1663175013000},"page":"2253-2259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-0538","authenticated-orcid":false,"given":"Malinda S.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-0402","authenticated-orcid":false,"given":"Ainhoa","family":"Gomez-Lumbreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-4595","authenticated-orcid":false,"given":"Lorenzo","family":"Villa-Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-9394","authenticated-orcid":false,"given":"Daniel C.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"5201_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","volume":"128","author":"A Slobodnick","year":"2015","unstructured":"Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S (2015) Colchicine: old and new. Am J Med 128:461\u2013470. https:\/\/doi.org\/10.1016\/j.amjmed.2014.12.010","journal-title":"Am J Med"},{"key":"5201_CR2","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1097\/01.mjt.0000433937.07244.e1","volume":"22","author":"J Stack","year":"2015","unstructured":"Stack J, Ryan J, McCarthy G (2015) Colchicine. Am J Ther 22:e151\u2013e157. https:\/\/doi.org\/10.1097\/01.mjt.0000433937.07244.e1","journal-title":"Am J Ther"},{"key":"5201_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.15896","volume":"178","author":"B Dasgeb","year":"2018","unstructured":"Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL (2018) Colchicine: an ancient drug with novel applications. Br J Dermatol 178:350\u2013356. https:\/\/doi.org\/10.1111\/bjd.15896","journal-title":"Br J Dermatol"},{"key":"5201_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/jcm10040783","volume":"10","author":"F Atzeni","year":"2021","unstructured":"Atzeni F, Masala IF, Rodr\u00edguez-Carrio J, R\u00edos-Garc\u00e9s R, Gerratana E, La Corte L et al (2021) The rheumatology drugs for COVID-19 management: which and when? J Clin Med 10:783. https:\/\/doi.org\/10.3390\/jcm10040783","journal-title":"J Clin Med"},{"key":"5201_CR5","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"T Grosser","year":"2018","unstructured":"Grosser T, Smyth E, FitzGerald G (2018) Pharmacotherapy of inflammation, fever, pain, and gout. In: Brunton LL et al (eds) Goodman and Gilman\u2019s the pharmacological basis of therapeutics, 13th edn. McGraw-Hill Education, New York","edition":"13"},{"key":"5201_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-2120-7","author":"S Stewart","year":"2020","unstructured":"Stewart S, Yang KCK, Atkins K, Dalbeth N, Robinson PC (2020) Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthr Res Ther. https:\/\/doi.org\/10.1186\/s13075-020-2120-7","journal-title":"Arthr Res Ther"},{"key":"5201_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2459\/JCM.0000000000001157","volume":"22","author":"A Andreis","year":"2021","unstructured":"Andreis A, Imazio M, Avondo S, Casula M, Paneva E, Piroli F et al (2021) Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials. J Cardiovasc Med 22:637\u2013644. https:\/\/doi.org\/10.2459\/JCM.0000000000001157","journal-title":"J Cardiovasc Med"},{"key":"5201_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","volume":"316","author":"RW Kuncl","year":"1987","unstructured":"Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M (1987) Colchicine myopathy and neuropathy. N Engl J Med 316:1562\u20131568. https:\/\/doi.org\/10.1056\/NEJM198706183162502","journal-title":"N Engl J Med"},{"key":"5201_CR9","first-page":"S13","volume":"20","author":"MR Altiparmak","year":"2002","unstructured":"Altiparmak MR, Pamuk ON, Pamuk GE, Hamuryudan V, Ataman R, Serdengecti K (2002) Colchicine neuromyopathy: a report of six cases. Clin Exp Rheumatol 20:S13\u2013S16","journal-title":"Clin Exp Rheumatol"},{"key":"5201_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","volume":"48","author":"Y Finkelstein","year":"2010","unstructured":"Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G et al (2010) Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol 48:407\u2013414. https:\/\/doi.org\/10.3109\/15563650.2010.495348","journal-title":"Clin Toxicol"},{"key":"5201_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/emj.19.3.265","volume":"19","author":"MJ Maxwell","year":"2002","unstructured":"Maxwell MJ (2002) Accidental colchicine overdose. A case report and literature review. Emerg Med J 19:265\u2013266. https:\/\/doi.org\/10.1136\/emj.19.3.265","journal-title":"Emerg Med J"},{"key":"5201_CR12","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","volume":"63","author":"RA Terkeltaub","year":"2011","unstructured":"Terkeltaub RA, Furst DE, DiGiacinto JL, Kook KA, Davis MW (2011) Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors. Arthr Rheum 63:2226\u20132237. https:\/\/doi.org\/10.1002\/art.30389","journal-title":"Arthr Rheum"},{"key":"5201_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13405","volume":"32","author":"S Beaudreuil","year":"2018","unstructured":"Beaudreuil S, Schermann JM, Verstuyft C, Barrail-Tran A, Smirnova M, Durrbach A et al (2018) Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients. Clin Transplant 32:e13405. https:\/\/doi.org\/10.1111\/ctr.13405","journal-title":"Clin Transplant"},{"key":"5201_CR14","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150317","author":"KV Ledwitch","year":"2016","unstructured":"Ledwitch KV, Barnes RW, Roberts AG (2016) Unravelling the complex drug\u2013drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20150317"},{"key":"5201_CR15","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1345\/aph.1E197","volume":"38","author":"F Rollot","year":"2004","unstructured":"Rollot F, Pajot O, Chauvelot-Moachon L, Nazal EM, K\u00e9la\u00efdi C, Blanche P (2004) Acute colchicine intoxication during clarithromycin administration. Ann Pharmacother 38:2074\u20132077. https:\/\/doi.org\/10.1345\/aph.1E197","journal-title":"Ann Pharmacother"},{"key":"5201_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/RHU.0b013e3181bbbcd7","volume":"15","author":"J McKinnell","year":"2009","unstructured":"McKinnell J, Tayek JA (2009) Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. JCR J Clin Rheumatol 15:303\u2013305. https:\/\/doi.org\/10.1097\/RHU.0b013e3181bbbcd7","journal-title":"JCR J Clin Rheumatol"},{"key":"5201_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00296-017-3823-1","volume":"38","author":"S Haj Yahia","year":"2018","unstructured":"Haj Yahia S, Ben Zvi I, Livneh A (2018) Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. Rheumatol Int 38:141\u2013147. https:\/\/doi.org\/10.1007\/s00296-017-3823-1","journal-title":"Rheumatol Int"},{"key":"5201_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12890\/2019_001066","volume":"6","author":"JM Olmos-Mart\u00ednez","year":"2019","unstructured":"Olmos-Mart\u00ednez JM, Molina H, Salas C, Olmos JM, Hern\u00e1ndez JL (2019) Acute colchicine-induced neuromyopathy in a patient treated with atorvastatin and clarithromycin. Eur J Case Reports Intern Med 6:1. https:\/\/doi.org\/10.12890\/2019_001066","journal-title":"Eur J Case Reports Intern Med"},{"key":"5201_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1248\/bpb.b20-00314","volume":"43","author":"S Imai","year":"2020","unstructured":"Imai S, Momo K, Kashiwagi H, Miyai T, Sugawara M, Takekuma Y (2020) Prescription of colchicine with other dangerous concomitant medications: a nation-wide survey using the Japanese claims database. Biol Pharm Bull 43:1519\u20131525. https:\/\/doi.org\/10.1248\/bpb.b20-00314","journal-title":"Biol Pharm Bull"},{"key":"5201_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.therap.2020.06.003","volume":"75","author":"M Girard de Courtilles","year":"2020","unstructured":"Girard de Courtilles M, Balusson F, Queric C, Bouric S, Carlhant-Kowalski D, Scailteux L-M et al (2020) Interactions m\u00e9dicamenteuses avec la colchicine, les contre-indications sont-elles bien respect\u00e9es\u202f? \u00c9tude descriptive des prescriptions en Bretagne \u00e0 partir des donn\u00e9es de l\u2019Assurance maladie. Therapies 75:675\u2013679. https:\/\/doi.org\/10.1016\/j.therap.2020.06.003","journal-title":"Therapies"},{"key":"5201_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"5201_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","volume":"84","author":"G Melli","year":"2005","unstructured":"Melli G, Chaudhry V, Cornblath DR (2005) Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 84:377\u2013385. https:\/\/doi.org\/10.1097\/01.md.0000188565.48918.41","journal-title":"Medicine (Baltimore)"},{"key":"5201_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00002018-199513020-00005","volume":"13","author":"N-A von Rosenstiel","year":"1995","unstructured":"von Rosenstiel N-A, Adam D (1995) Macrolide antibacterials. Drug Saf 13:105\u2013122. https:\/\/doi.org\/10.2165\/00002018-199513020-00005","journal-title":"Drug Saf"},{"key":"5201_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3109\/15563650.2011.589844","volume":"49","author":"M Mullins","year":"2011","unstructured":"Mullins M, Cannarozzi AA, Bailey TC, Ranganathan P (2011) Unrecognized fatalities related to colchicine in hospitalized patients. Clin Toxicol 49:648\u2013652. https:\/\/doi.org\/10.3109\/15563650.2011.589844","journal-title":"Clin Toxicol"},{"key":"5201_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40264-020-00930-7","volume":"43","author":"L Villa Zapata","year":"2020","unstructured":"Villa Zapata L, Hansten PD, Horn JR, Boyce RD, Gephart S, Subbian V et al (2020) Evidence of clinically meaningful drug\u2013drug interaction with concomitant use of colchicine and clarithromycin. Drug Saf 43:661\u2013668. https:\/\/doi.org\/10.1007\/s40264-020-00930-7","journal-title":"Drug Saf"},{"key":"5201_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/431592","volume":"41","author":"IFN Hung","year":"2005","unstructured":"Hung IFN, Wu AKL, Cheng VCC, Tang BSF, To KW, Yeung CK et al (2005) Fatal Interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis 41:291\u2013300. https:\/\/doi.org\/10.1086\/431592","journal-title":"Clin Infect Dis"},{"key":"5201_CR27","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s11739-021-02654-7","volume":"16","author":"A Andreis","year":"2021","unstructured":"Andreis A, Imazio M, Casula M, Avondo S, De Ferrari GM (2021) Colchicine efficacy and safety for the treatment of cardiovascular diseases. Intern Emerg Med 16:1691\u20131700. https:\/\/doi.org\/10.1007\/s11739-021-02654-7","journal-title":"Intern Emerg Med"},{"key":"5201_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","volume":"2","author":"S Deftereos","year":"2014","unstructured":"Deftereos S, Giannopoulos G, Panagopoulou V, Bouras G, Raisakis K, Kossyvakis C et al (2014) Anti-inflammatory treatment with colchicine in stable chronic heart failure. JACC Hear Fail 2:131\u2013137. https:\/\/doi.org\/10.1016\/j.jchf.2013.11.006","journal-title":"JACC Hear Fail"},{"key":"5201_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1345\/aph.10184","volume":"35","author":"AJ Dixon","year":"2001","unstructured":"Dixon AJ, Wall GC (2001) Probable colchicine-induced neutropenia not related to intentional overdose. Ann Pharmacother 35:192\u2013195. https:\/\/doi.org\/10.1345\/aph.10184","journal-title":"Ann Pharmacother"},{"key":"5201_CR30","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.ejim.2008.09.012","volume":"20","author":"M Demy","year":"2009","unstructured":"Demy M, Varache N, Coindre J-P, Dernis E, Pu\u00e9chal X (2009) Recurrent and fatal pancytopenia due to repeated colchicine self administration. Eur J Intern Med 20:e116\u2013e117. https:\/\/doi.org\/10.1016\/j.ejim.2008.09.012","journal-title":"Eur J Intern Med"},{"key":"5201_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","volume":"45","author":"YY Leung","year":"2015","unstructured":"Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine\u2014update on mechanisms of action and therapeutic uses. Semin Arthr Rheum 45:341\u2013350. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.013","journal-title":"Semin Arthr Rheum"},{"key":"5201_CR32","unstructured":"Food and Drug Administration (2020) Clinical drug interaction studies-cytochrome P450 enzyme- and transporter-mediated drug interactions guidance for industry. Center for Drug Evaluation and Research (CDER), US Department of Health and Human Services and Food and Drug Administration, Silver Springs"},{"key":"5201_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00228-017-2357-5","volume":"74","author":"WY Zheng","year":"2018","unstructured":"Zheng WY, Richardson LC, Li L, Day RO, Westbrook JI, Baysari MT (2018) Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol 74:15\u201327. https:\/\/doi.org\/10.1007\/s00228-017-2357-5","journal-title":"Eur J Clin Pharmacol"},{"key":"5201_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","volume":"289","author":"DN Juurlink","year":"2003","unstructured":"Juurlink DN (2003) Drug\u2013drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289:1652. https:\/\/doi.org\/10.1001\/jama.289.13.1652","journal-title":"JAMA"},{"key":"5201_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T (2015) The rising tide of polypharmacy and drug\u2013drug interactions: population database analysis 1995\u20132010. BMC Med 13:74. https:\/\/doi.org\/10.1186\/s12916-015-0322-7","journal-title":"BMC Med"},{"key":"5201_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/pharmaceutics13020266","volume":"13","author":"M Bories","year":"2021","unstructured":"Bories M, Bouzill\u00e9 G, Cuggia M, Le Corre P (2021) Drug\u2013drug interactions in elderly patients with potentially inappropriate medications in primary care, nursing home and hospital settings: a systematic review and a preliminary study. Pharmaceutics 13:266. https:\/\/doi.org\/10.3390\/pharmaceutics13020266","journal-title":"Pharmaceutics"},{"key":"5201_CR37","unstructured":"Web MD. Drug Interaction Checker. https:\/\/www.webmd.com\/interaction-checker\/default.htm. Accessed Sept 2021"},{"key":"5201_CR38","unstructured":"Drugs.com. Drug Interactions Checker. https:\/\/www.drugs.com\/drug_interactions.htm. Accessed Sept 2021"},{"key":"5201_CR39","unstructured":"Medscape. Drug Interaction Checker. https:\/\/reference.medscape.com\/drug-interactionchecker. Accessed Sept 2021"},{"key":"5201_CR40","unstructured":"RxList. Drug Interaction Checker. https:\/\/www.rxlist.com\/drug-interaction-checker.htm. Accessed Sept 2021"},{"key":"5201_CR41","unstructured":"Wolters Kluwer. Lexicomp: interactions. Drugs Interaction Checker. https:\/\/www.wolterskluwer.com\/en\/solutions\/lexicomp\/resources\/facts-comparisons-user-academy\/druginteractions.\nAccessed Sept 2021"},{"key":"5201_CR42","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","volume":"9","author":"J-C Tardif","year":"2021","unstructured":"Tardif J-C, Bouabdallaoui N, L\u2019Allier PL, Gaudet D, Shah B, Pillinger MH et al (2021) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med 9:924\u2013932. https:\/\/doi.org\/10.1016\/S2213-2600(21)00222-8","journal-title":"Lancet Respir Med"},{"key":"5201_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13645","author":"MN Elshafei","year":"2021","unstructured":"Elshafei MN, El-Bardissy A, Khalil A, Danjuma M, Mubasher M, Abubeker IY et al (2021) Colchicine use might be associated with lower mortality in COVID-19 patients: a meta-analysis. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/eci.13645","journal-title":"Eur J Clin Invest"},{"key":"5201_CR44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/life11080864","volume":"11","author":"C-H Lien","year":"2021","unstructured":"Lien C-H, Lee M-D, Weng S-L, Lin C-H, Liu LY-M, Tai Y-L et al (2021) Repurposing colchicine in treating patients with COVID-19: a systematic review and meta-analysis. Life 11:864. https:\/\/doi.org\/10.3390\/life11080864","journal-title":"Life"},{"key":"5201_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00505-8","author":"K Tsiakos","year":"2021","unstructured":"Tsiakos K, Tsakiris A, Tsibris G, Voutsinas P-M, Panagopoulos P, Kosmidou M et al (2021) Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: The ACHIEVE open-label single-arm trial. Infect Dis Ther. https:\/\/doi.org\/10.1007\/s40121-021-00505-8","journal-title":"Infect Dis Ther"},{"key":"5201_CR46","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","volume":"72","author":"VM Vaughn","year":"2021","unstructured":"Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN et al (2021) Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis 72:e533\u2013e541. https:\/\/doi.org\/10.1093\/cid\/ciaa1239","journal-title":"Clin Infect Dis"},{"key":"5201_CR47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.2021.11517","volume":"326","author":"CE Oldenburg","year":"2021","unstructured":"Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L et al (2021) Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection. JAMA 326:490. https:\/\/doi.org\/10.1001\/jama.2021.11517","journal-title":"JAMA"},{"key":"5201_CR48","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/ctr.12448","volume":"28","author":"A Amanova","year":"2014","unstructured":"Amanova A, Kendi Celebi Z, Bakar F, Caglayan MG, Keven K (2014) Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. Clin Transplant 28:1177\u20131183. https:\/\/doi.org\/10.1111\/ctr.12448","journal-title":"Clin Transplant"},{"key":"5201_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/431592","volume":"41","author":"IFN Hung","year":"2005","unstructured":"Hung IFN, Wu AKL, Cheng VCC, Tang BSF, To KW, Yeung CK, Woo PCY, Lau SKP, Cheung BMY, Yuen KY (2005) Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis 41:291\u2013200","journal-title":"Clin Infect Dis"},{"key":"5201_CR50","doi-asserted-by":"publisher","first-page":"e7182","DOI":"10.1371\/journal.pone.0007182","volume":"4","author":"AA Kumar","year":"2009","unstructured":"Kumar AA, Bhaskar E, Palamaner Subash Shantha G, Swaminathan P, Abraham G (2009) Rhabdomyolysis in community acquired bacterial sepsis\u2013a retrospective cohort study. PLoS ONE 4:e7182. https:\/\/doi.org\/10.1371\/journal.pone.0007182","journal-title":"PLoS ONE"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05201-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05201-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05201-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:40:58Z","timestamp":1744206058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05201-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5201"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05201-5","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20150317","asserted-by":"subject"}]},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}